Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial - Gertz, Morie A.; Cohen, Adam D.; Comenzo, Raymond L.; Kastritis, Efstathios; Landau, Heather J.; Libby, Edward N.; Liedtke, Michaela; Sanchorawala, Vaishali; Schönland, Stefan; Wechalekar, Ashutosh; Zonder, Jeffrey A.; Palladini, Giovanni; et al. (Blood, 2023)
Gesehen am 19.03.2024